Edition:
United States

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,501JPY
25 May 2017
Change (% chg)

¥0 (+0.00%)
Prev Close
¥1,501
Open
¥1,498
Day's High
¥1,503
Day's Low
¥1,487
Volume
1,415,600
Avg. Vol
1,803,326
52-wk High
¥1,748
52-wk Low
¥1,251

Summary

Name Age Since Current Position

Akira Kurokawa

64 2008 President, Chief Executive Officer, Representative Director

Kazuo Koshiji

2016 Chief Financial Officer, Managing Executive Officer, Chief Director of Finance

Sadatoshi Furukado

63 2014 Executive Vice President, Director

Noriaki Yamamoto

Chief Information Officer, Executive Officer, Chief Director of Information System

Naveed Shams

2017 Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development

Masamichi Sato

2017 Managing Executive Officer, Chief Compliance Officer, Chief Director of CSR & Internal Control

Takeshi Ito

2016 Senior Managing Executive Officer, Director of Pharmaceutical Business

Akihiro Tsujimura

2017 Senior Managing Executive Officer, Director of Asia Business, President & Chief Executive Officer of Subsidiary

Atsutoshi Ohta

Managing Executive Officer, Chief Director of Human Resources Development

Shigeo Taniuchi

2017 Managing Executive Officer, President of Subsidiary

Takahiro Morita

2017 Executive Officer, Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit

Akio Kimura

2017 Executive Officer, Chief Director of Product Supply, Chief Director of Reliability Guarantee

Ye Liu

Executive Officer, General Manager of Subsidiary

Kenji Morishima

2016 Executive Officer, Senior Director of Pharmaceutical Technology in Main Research & Development Unit

Satoshi Suzuki

2017 Executive Officer, Chief Director of Planning

Takayuki Katayama

71 2012 Independent Director

Kanoko Ohishi

56 2015 Independent Director

Akihiro Okumura

71 2011 Independent Director

Biographies

Name Description

Akira Kurokawa

Mr. Akira Kurokawa has been serving as President, Chief Executive Officer and Representative Director in Santen Pharmaceutical Co., Ltd. since June 25, 2008. He joined the Company in April 1977. His previous titles include Director of Pharmaceutical Business, Managing Executive Officer and Chief Operating Officer in the Company. He used to serve as President and Director in a subsidiary, Santen Holdings U.S. Inc.

Kazuo Koshiji

Sadatoshi Furukado

Mr. Sadatoshi Furukado resigned from the position of Executive Vice President and Director in Santen Pharmaceutical Co., Ltd. effective June 23, 2017. He joined the Company in April 1977. His previous titles include Senior Managing Executive Officer, Senior Director of Medicine Sales, Executive Officer and Managing Executive Officer in the Company.

Noriaki Yamamoto

Naveed Shams

Masamichi Sato

Takeshi Ito

Akihiro Tsujimura

Atsutoshi Ohta

Shigeo Taniuchi

Takahiro Morita

Akio Kimura

Ye Liu

Kenji Morishima

Satoshi Suzuki

Takayuki Katayama

Mr. Takayuki Katayama has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2012. He is also working for Teijin Limited and Toyo Seikan Group Holdings, Ltd.

Kanoko Ohishi

Ms. Kanoko Ohishi has been serving as Independent Director in Santen Pharmaceutical Co., Ltd. since June 2015. She is also serving as Independent Director in EZAKI GLICO CO., LTD., Suruga Bank Ltd. and Shiseido Company, Limited, as well as Representative Director in Mediva Inc. and another company, and working for Medical Corporation Platanus. She used to work for McKinsey & Company, Inc. and Astellas Pharma Inc.

Akihiro Okumura

Mr. Akihiro Okumura resigned from the position of Independent Director in Santen Pharmaceutical Co., Ltd. effective June 23, 2017. He is also working for University of Shizuoka. He is also an Honorary Professor of Keio University.